A Double-blind, Randomized, Parallel, Active-controlled, Non-inferiority, Phase III Clinical Trial to Compare the Efficacy and Safety of HG-102 Versus Botox ® in Subjects With Moderate to Severe Glabellar Lines
Condition: Glabellar Lines Interventions: Drug: Botulinum Toxin Type A Injection [HG-102]; Drug: Botulinum Toxin Type A Injection [Botox] Sponsor: Hugel Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 6, 2023 Category: Research Source Type: clinical trials
A Double-blind, Randomized, Parallel, Active-controlled, Non-inferiority, Phase III Clinical Trial to Compare the Efficacy and Safety of HG102 Versus Botox ® in Subjects With Moderate to Severe Glabellar Lines
Condition: Glabellar Lines Interventions: Drug: Botulinum Toxin Type A Injection [HG102]; Drug: Botulinum Toxin Type A Injection [Botox] Sponsor: Hugel Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 6, 2023 Category: Research Source Type: clinical trials
A Double-blind, Randomized, Parallel, Active-controlled, Non-inferiority, Phase III Clinical Trial to Compare the Efficacy and Safety of HG-102 Versus Botox ® in Subjects With Moderate to Severe Glabellar Lines
Condition: Glabellar Lines Interventions: Drug: Botulinum Toxin Type A Injection [HG-102]; Drug: Botulinum Toxin Type A Injection [Botox] Sponsor: Hugel Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 6, 2023 Category: Research Source Type: clinical trials
Effect of Additional Topical Diltiazem on Botulinum Toxin Injection for Chronic Anal Fissure
Condition: Anal Fissure Chronic Interventions: Drug: Botulinum Toxin Type A Injection [Botox]; Drug: Botulinum Toxin Type A Injection [Botox] + Diltiazem Hydrochloride 20 Mg/G Rectal Gel Sponsor: Istanbul Medipol University Hospital Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 4, 2023 Category: Research Source Type: clinical trials